Increased cerebrospinal fluid glutamine levels in depressed patients
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background There is increasing evidence for an association between alterations of brain glutamatergic neurotransmission and the pathophysiology of affective disorders. Methods We studied the association between cerebrospinal fluid (CSF) metabolites, including glutamine, in unipolar and bipolar depressed patients versus control subjects using a proton magnetic resonance spectroscopy technique. Cerebrospinal fluid samples were obtained from 18 hospitalized patients with acute unmedicated severe depression without medical problems and compared with those of 22 control subjects. Results Compared with the control group, the depressed patient group had significantly higher CSF glutamine concentrations, which correlated positively with CSF magnesium levels. Conclusions These findings suggest an abnormality of the brain glial-neuronal glutamine/glutamate cycle associated with N-methyl-D-aspartate receptor systems in patients with depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some have reported increased glutamate levels in the plasma of untreated MDD patients157, 158 in line with reports of high CSF glutamate concentrations in severely depressed, hospitalized MDD patients159 and in untreated elderly MDD patients when compared to healthy controls160.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [158]
In the citing paper
“As increased glutamate levels are observed in the brains of animals exposed to stress [118,119] and in depressed individuals [120,121], understanding the importance of the regulation of glutamatergic neurotransmission in stress and depression are crucial.”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [121]
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785
Maes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Gastel, A. V., Neels, H., Demedts, P., Wauters, A., & Meltzer, H. Y. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09622.x · Cited by 356
Plasma cholesterol and depressive symptoms in older men
Morgan, R. E., Palinkas, L. A., Barrett-Connor, E. L., & Wingard, D. L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92556-9 · Cited by 306
Nowak, G., Ordway, G. A., & Paul, I. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00057-w · Cited by 262
CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.8.1098 · Cited by 259
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243
Double-blind, controlled trial of inositol treatment of depression
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.792 · Cited by 230
Research works printed but not linked: 3
- American Psychiatric Association (1987): Diagnostic and Statistical Manual of Psychiatric Disorders, 3rd rev ed. Washington, DC: American Psychiatric Press.
- Niklasson, 1984, Brain energy metabolism and blood-brain barrier permeability in depressive patients, Biol Psychiatry, 19, 1183
- Nowak, 1993, Adaptation of the N-methyl-D-aspartate receptor following chronic antidepressants. (abstract), J Neurochem, 61, S51
Cited by
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
“…sample of individuals with major depressive and bipolar disorder (Frye et al., 2007a) and an earlier study of CSF samples was unable to effectively measure glutamate levels but did report significantly higher CSF glutamine concentrations in subjects with major depression (Levine et al., 2000).”
ResultTargeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
“, 1998) and increased concentration of glutamine in cerebrospinal fluid (Levine et al., 2000).”
BackgroundInfluentialMagnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Yüksel, C., & Öngür, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.016 · Cited by 493
“Cerebrospinal fluid glutamate levels were found to be high or normal in patients with major depressive disorder [42,43], and low in a mixed group with bipolar disorder and major depressive disorder patients [44].”
Background
Metadata
- Authors
- Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- University of Pittsburgh (US)
- Wolfson Medical Center (IL)
- Corresponding author
- Pettegrew, Jay W
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 47
- Issue
- 7
- Pages
- 586-593
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1990428243
- Cited by
- 240
- References
- 0
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 5 · 2023: 8 · 2022: 14 · 2021: 35 · 2020: 14 · 2019: 14 · 2018: 6 · 2017: 12 · 2016: 6 · 2015: 14 · 2014: 9 · 2013: 5 · 2012: 14
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- depression, major depressive disorder, bipolar depression, glutamate-glutamine cycle, NMDA receptor, glutamatergic neurotransmission, 1H NMR
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Bipolar Disorder, Creatine, Depressive Disorder, Female, Glutamine, Humans, Hydroxybutyrates, Magnesium, Male, Middle Aged, Magnetic Resonance Spectroscopy, Sex Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased cerebrospinal fluid glutamine levels in depressed patients. https://app.cochat.ai/papers/10.1016/s0006-3223(99)00284-x
- The paper
- Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000). Increased cerebrospinal fluid glutamine levels in depressed patients. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(99)00284-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.